You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial

Article metrics

Article menu

Download PDFPDF

Late-Breaking Abstracts
Clinical Trial in Progress
1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial

 

Online download statistics by month:

Online download statistics by month: November 2023 to July 2025

AbstractFullPdf
Nov 20239208
Dec 20235705
Jan 20244004
Feb 20244802
Mar 20244002
Apr 20245203
May 20248502
Jun 202446011
Jul 20245005
Aug 20247104
Sep 20244502
Oct 20248604
Nov 20244803
Dec 20242402
Jan 202546010
Feb 2025904
Mar 2025003
Apr 2025006
May 2025008
Jun 2025004
Jul 2025002
Total839094